PROVIDER PROFILE · NPI 1255992293
Jason KaoPA
PRESCRIBING · PART D · 2024
Total Rx claims
1,172
Beneficiaries
—
Total drug cost
$8.6M
Distinct drugs
31
Brand share
55.0%
Top prescribed drugs
Osimertinib Mesylate348 claims
Apixaban104 claims
Alectinib Hcl57 claims
Ondansetron Hcl45 claims
Prednisone41 claims
QUALITY · MIPS · 2024
Final MIPS score
88.5
Quality
87.1
Cost
69.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.57%
Group
CROSS-REFERENCE